Clinical trial
Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization With Other Vaccines in Shanghai
NCT05166044 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization With Other Vaccines in Shanghai
- Lead sponsor
- Sinovac Biotech Co., Ltd
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 4, 2022
- Completion date
- August 10, 2022
- Enrollment
- 12,500 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.